Author

Omar Fakih

Observed name: O. Fakih

Institution: Clatterbridge Cancer Centre NHS Foundation Trust

Observed institutions: Clatterbridge Cancer Centre NHS Foundation Trust, The Christie Hospital, The Christie NHS Foundation Trust

ORCID: 0000-0002-3617-282X

Observed ORCID: 0000-0002-3617-282X

OpenAlex ID: A5090465201

Surgical and Pathological Results Following Neoadjuvant Nivolumab and Platinum-Based Chemotherapy for Locally Advanced Resectable NSCLC: A Multicentre Real-World Series From England

2024 · Alessandro Brunelli, Ross Hoffman, et al. · Clinical Lung Cancer · 10

Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis

2025 · Alessandro Brunelli, Alessio Mariolo, et al. · European Journal of Cardio-Thoracic Surgery · 5

Treatment with infliximab and tacrolimus in steroid-refractory pneumonitis secondary to anti-HER2 therapy

2025 · O. Fakih, E. Ahmed, et al. · ESMO Open · 1

ALBI grade predicts suitability for further systemic therapy following sorafenib in patients with advanced hepatocellular carcinoma

2022 · Omar Fakih, Suraiya S. Haddad, et al. · Liver Cancer International

Works count: 5

Citation count: 16

H-index: 2

I10-index: 1